2020年中国卒中疾病负担估计
该研究为基于2020年7月至12月中国大陆31个省份全国代表性调查的横断面研究,纳入676 394名40岁及以上成人,由受训神经科医师面对面标准化核实自报卒中。2020年中国卒中加权患病率2.6%(95%CI 2.6%-2.6%),发病率505.2/10万人年(95%CI 488.5-522.0),死亡率343.4/10万人年(95%CI 329.6-357.2);估计新发340万例、患病1780万例、死亡230万例。缺血性卒中占新发卒中的86.8%(1550万例),脑出血占11.9%(210万例),蛛网膜下腔出血占1.3%(20万例)。城市患病率高于农村(2.7% vs 2.5%,P=.02),但城市发病率(485.5 vs 520.8/10万人年,P<.001)和死亡率(309.9 vs 369.7/10万人年,P<.001)低于农村;高血压为首位危险因素(OR 3.20,95%CI 3.09-3.32)。作者认为需改进中国普通人群的卒中预防策略。
要点
- 2020年中国40岁及以上人群卒中加权患病率2.6%(95%CI 2.6%-2.6%),估计患病1780万例(95%CI 17.5-18.0百万)。
- 2020年卒中发病率505.2/10万人年(95%CI 488.5-522.0),估计新发340万例(95%CI 3.3-3.6百万)。
- 2020年卒中死亡率343.4/10万人年(95%CI 329.6-357.2),估计死亡230万例(95%CI 2.2-2.4百万)。
- 城市患病率高于农村(2.7% vs 2.5%,P=.02),但城市发病率(485.5 vs 520.8/10万人年,P<.001)和死亡率(309.9 vs 369.7/10万人年,P<.001)低于农村。
- 新发卒中以缺血性为主(1550万例,86.8%),脑出血210万例(11.9%),蛛网膜下腔出血20万例(1.3%);高血压为首位危险因素(OR 3.20,95%CI 3.09-3.32)。
适用人群与场景
- 中国31个省份40岁及以上成人,共676 394人(女性395 122人,占58.4%;平均年龄59.7岁,SD 11.0岁)。
- 全国代表性调查,2020年7月至12月面对面访谈,由受训神经科医师按标准化方案核实自报卒中。
诊断标准与关键阈值
- 卒中由受训神经科医师面对面标准化方案核实自报诊断。
- 发病率定义为调查前1年内发生的首次卒中;调查前1年内因卒中死亡者计为死亡病例。
研究设计与关键结果
- 横断面研究,纳入676 394名40岁及以上中国成人,2020年7月至12月在31个省份开展。
- 2020年卒中加权患病率2.6%(95%CI 2.6%-2.6%),发病率505.2/10万人年(95%CI 488.5-522.0),死亡率343.4/10万人年(95%CI 329.6-357.2)。
- 估计2020年40岁及以上人群新发卒中340万例(95%CI 3.3-3.6百万),患病1780万例(95%CI 17.5-18.0百万),死亡230万例(95%CI 2.2-2.4百万)。
- 缺血性卒中1550万例(86.8%,95%CI 15.2-15.6百万),脑出血210万例(11.9%,95%CI 2.1-2.1百万),蛛网膜下腔出血20万例(1.3%,95%CI 0.2-0.2百万)。
- 城市患病率2.7%(95%CI 2.6%-2.7%)高于农村2.5%(95%CI 2.5%-2.6%),P=.02。
- 城市发病率485.5/10万人年(95%CI 462.8-508.3)低于农村520.8/10万人年(95%CI 496.3-545.2),P<.001。
- 城市死亡率309.9/10万人年(95%CI 291.7-328.1)低于农村369.7/10万人年(95%CI 349.1-390.3),P<.001。
- 首位危险因素为高血压(OR 3.20,95%CI 3.09-3.32)。
证据类型、等级与局限
- 证据类型:基于全国代表性调查的横断面研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,2020年中国40岁及以上人群卒中患病率、发病率与死亡率数据提示需要改进中国普通人群的卒中预防策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Stroke is the leading cause of death in China. However, recent data about the up-to-date stroke burden in China are limited.
OBJECTIVE: To investigate the urban-rural disparity of stroke burden in the Chinese adult population, including prevalence, incidence, and mortality rate, and disparities between urban and rural populations.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was based on a nationally representative survey that included 676 394 participants aged 40 years and older. It was conducted from July 2020 to December 2020 in 31 provinces in mainland China.
MAIN OUTCOMES AND MEASURES: Primary outcome was self-reported stroke verified by trained neurologists during a face-to-face interviews using a standardized protocol. Stroke incidence were assessed by defining first-ever strokes that occurred during 1 year preceding the survey. Strokes causing death that occurred during the 1 year preceding the survey were considered as death cases.
RESULTS: The study included 676 394 Chinese adults (395 122 [58.4%] females; mean [SD] age, 59.7 [11.0] years). In 2020, the weighted prevalence, incidence, and mortality rates of stroke in China were 2.6% (95% CI, 2.6%-2.6%), 505.2 (95% CI, 488.5-522.0) per 100 000 person-years, and 343.4 (95% CI, 329.6-357.2) per 100 000 person-years, respectively. It was estimated that among the Chinese population aged 40 years and older in 2020, there were 3.4 (95% CI, 3.3-3.6) million incident cases of stroke, 17.8 (95% CI, 17.5-18.0) million prevalent cases of stroke, and 2.3 (95% CI, 2.2-2.4) million deaths from stroke. Ischemic stroke constituted 15.5 (95% CI, 15.2-15.6) million (86.8%) of all incident strokes in 2020, while intracerebral hemorrhage constituted 2.1 (95% CI, 2.1-2.1) million (11.9%) and subarachnoid hemorrhage constituted 0.2 (95% CI, 0.2-0.2) million (1.3%). The prevalence of stroke was higher in urban than in rural areas (2.7% [95% CI, 2.6%-2.7%] vs 2.5% [95% CI, 2.5%-2.6%]; P = .02), but the incidence rate (485.5 [95% CI, 462.8-508.3] vs 520.8 [95% CI, 496.3-545.2] per 100 000 person-years; P < .001) and mortality rate (309.9 [95% CI, 291.7-328.1] vs 369.7 [95% CI, 349.1-390.3] per 100 000 person-years; P < .001) were lower in urban areas than in rural areas. In 2020, the leading risk factor for stroke was hypertension (OR, 3.20 [95% CI, 3.09-3.32]).
CONCLUSIONS AND RELEVANCE: In a large, nationally representative sample of adults aged 40 years or older, the estimated prevalence, incidence, and mortality rate of stroke in China in 2020 were 2.6%, 505.2 per 100 000 person-years, and 343.4 per 100 000 person-years, respectively, indicating the need for an improved stroke prevention strategy in the general Chinese population.
参考来源
- Tu WJ, Zhao Z, Yin P, et al. Estimated Burden of Stroke in China in 2020. JAMA Netw Open. 2023. PMID: 36862407. doi:10.1001/jamanetworkopen.2023.1455
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。